CCL4 and myeloid sarcoma: HGF and Eotaxin/CCL11 with O.R. >1 (Table 4) are risk factors for developing a progressive clinical form of MS, while EGF and MIP-1β/CCL4 with O.R. <1 are protective factors for developing a progressive clinical form of MS.